Microban® - Your Trusted Advisor for Antiviral Product Testing and Registration

COVID-19 has emphasized the importance of environmental cleanliness and hygiene management – whether that environment be in your home, your workplace, or at your services, entertainment, and healthcare provider locations. As the trusted leader in antimicrobial technology, Microban has seen an increased interest from manufacturers in wanting to understand if and how antimicrobial technology can contribute to the fight against SARS CoV-2, the virus that causes COVID-19, and other viruses. Microban stands ready to serve as your industry partner and offers custom development services for antiviral treated articles and antiviral built in solutions.

For over 35 years, Microban has redefined clean with protection that lives on by offering antimicrobial and odor control solutions in over 50 countries. And recently with the launches of the Microban 24 residual sanitization product line (with partner P&G) and the Sani-24 continuously active disinfectant line (with partner PDI), our materials protection and cleaning products are bringing differentiated performance to more households and businesses than ever before. We work with our partners to provide antimicrobial product solutions and provide best-in-class sales, marketing, technical, and regulatory support to ensure successful commercialization. Our expertise in improving product performance and in regulatory guidance is increasingly vital given the interest in viruses brought out by the COVID-19 contagion.

At Microban, we understand the process and framework for making antiviral claims on treated articles. While Microban products serve an important role in providing effective antimicrobial benefits and solutions, antiviral claims are not allowed without proven efficacy and proper registration with governing bodies.

Microban believes in engaging partners interested in pursuing antiviral claims on treated articles in a regulatorily and legally compliant manner and have a 4-step approach to successful commercialization.

Our approach ensures:

  1. testing against relevant viruses, starting with initial rapid screening with appropriate bacteriophage and viral surrogates leading to testing viral species of interest
  2. consideration of virus behavior on treated articles
  3. evaluation of results for significant log reduction, and
  4. proper registration with governing bodies to make antiviral claims in the region of interest

As partners and manufacturers look to smart technologies that improve overall environmental cleanliness as well as deliver anti-microbial and antiviral performance, it is essential that you consider working with Microban - a trusted advisor with a deep understanding of the global regulatory and legal landscapes. We are prepared to work with you should you have interest in pursuing antiviral efficacy claims for your treated articles.

Microban is here to support, as we have for over 35 years. We are well prepared to engage with you on your product performance projects and all other antimicrobial technology needs.

We are in this together.

For more information, contact a member of the Microban team today.